CJC-1295 w/ DAC 5MG

Description

CJC 1295 (with DAC)

CJC 1295 (with DAC) is a long acting growth hormone releasing hormone (GHRH) analog studied in research settings for its extended activity profile and use in evaluating GHRH receptor related pathways in controlled experimental models. It is commonly investigated in endocrine signaling research, including comparative protocol design and assay based exploration of downstream signaling cascades, depending on the model and study parameters.

Product Details

Concentration: 5 mg per vial
Purity: 99 percent or greater (COA verified)
Manufacturing: USA, GMP compliant facility
Format: Lyophilized powder intended for laboratory reconstitution
Use: Research Use Only

Product Care and Storage

Store refrigerated at 36°F to 46°F (2°C to 8°C).
Keep sealed in the original container and protect from light.
Avoid repeated temperature fluctuations and unnecessary handling.
After reconstitution, store according to your laboratory SOP and any applicable lot documentation.

Documentation and Verification

Moon Peptides supports lot traceability and independent verification. Certificates of Analysis are available for specific lots upon request so researchers can document identity and reported purity results for their records.

Product Note

This product is intended strictly for research use only. Not for human consumption. Not for clinical, diagnostic, therapeutic, or veterinary use. Not for unsupervised or recreational use.

The Science

In research contexts, CJC 1295 with DAC is studied for its Drug Affinity Complex design, which promotes albumin binding and is commonly discussed as a mechanism for extending functional exposure compared with non DAC GHRH analogs. This extended activity profile is used in experimental protocols that examine growth hormone release dynamics and IGF 1 related signaling in controlled systems, including work focused on timing, sampling design, analytical measurement, and pathway level characterization.